Harvard Business School professor Leemore Dafny lays out potential reforms to assist agencies in halting anticompetitive acquisitions and practices, and to preserve and promote...
Increasing concentration is not unique to the US—recent studies show that concentration is rising in Europe as well, although to a lesser extent than...
The dominant platforms have proven themselves to be ungovernable. Behavioral remedies, especially those that require continuous oversight, might be pushed aside. The only issue...
Pharmacy Benefit Managers (PBMs) were established in the 1960s to control drug costs but have since morphed into one of the most highly concentrated...
Assuming Facebook’s acquisitions can be shown to have eliminated emerging rivals, reversing those acquisitions via divestiture—“the most important of antitrust remedies”—is the logical place...
How will US antitrust policy look under President Joe Biden? We caught up with four antitrust experts—Jonathan Baker, Zephyr Teachout, William Kovacic, and Teddy...
The Biden Administration can revive federal antimonopoly enforcement after 40 years of little action, even when faced with congressional opposition. Here’s how.
The new Biden...
Real antitrust reform of the kind offered by the Judiciary Antitrust Subcommittee is needed to assist enforcers in precisely the types of competitive harms...